Orit Picard

3.2k total citations
67 papers, 2.3k citations indexed

About

Orit Picard is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Orit Picard has authored 67 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 33 papers in Immunology and 26 papers in Epidemiology. Recurrent topics in Orit Picard's work include Inflammatory Bowel Disease (35 papers), Immunodeficiency and Autoimmune Disorders (18 papers) and Microscopic Colitis (17 papers). Orit Picard is often cited by papers focused on Inflammatory Bowel Disease (35 papers), Immunodeficiency and Autoimmune Disorders (18 papers) and Microscopic Colitis (17 papers). Orit Picard collaborates with scholars based in Israel, France and China. Orit Picard's co-authors include Shomron Ben‐Horin, Ella Fudim, Yehuda Chowers, Miri Yavzori, Uri Kopylov, Rami Eliakim, Bella Ungar, D. Coscas, Batia Weiss and Matti Waterman and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Gut.

In The Last Decade

Orit Picard

64 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Orit Picard 1.5k 1.1k 1.1k 402 309 67 2.3k
Ella Fudim 1.4k 1.0× 1.0k 0.9× 998 0.9× 343 0.9× 279 0.9× 50 2.0k
Freddy Cornillie 2.1k 1.4× 1.6k 1.4× 1.6k 1.5× 1.1k 2.7× 495 1.6× 79 5.3k
Xavier Hébuterne 1.7k 1.2× 1.2k 1.1× 801 0.8× 795 2.0× 371 1.2× 73 2.9k
Francisco A. Bonilla 1.0k 0.7× 590 0.5× 2.8k 2.7× 232 0.6× 80 0.3× 33 3.5k
Marc Busson 549 0.4× 494 0.4× 2.1k 2.0× 430 1.1× 171 0.6× 110 3.8k
Liesbet Henckaerts 1.1k 0.7× 924 0.8× 567 0.5× 432 1.1× 134 0.4× 60 2.0k
Gilles Boschetti 1.1k 0.8× 944 0.8× 538 0.5× 778 1.9× 152 0.5× 89 2.0k
Maya Ram 253 0.2× 634 0.6× 539 0.5× 319 0.8× 117 0.4× 62 2.1k
J Hors 1.6k 1.1× 176 0.2× 1.2k 1.2× 1.0k 2.5× 221 0.7× 167 3.0k
David Hudesman 679 0.5× 650 0.6× 402 0.4× 358 0.9× 77 0.2× 87 1.7k

Countries citing papers authored by Orit Picard

Since Specialization
Citations

This map shows the geographic impact of Orit Picard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orit Picard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orit Picard more than expected).

Fields of papers citing papers by Orit Picard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orit Picard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orit Picard. The network helps show where Orit Picard may publish in the future.

Co-authorship network of co-authors of Orit Picard

This figure shows the co-authorship network connecting the top 25 collaborators of Orit Picard. A scholar is included among the top collaborators of Orit Picard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orit Picard. Orit Picard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levhar, Nina, Rotem Hadar, Orit Picard, et al.. (2024). DOP09 Models for predicting Crohn Disease (CD) exacerbation using serum and fecal metabolomics. Journal of Crohn s and Colitis. 18(Supplement_1). i88–i89. 1 indexed citations
2.
Yavzori, Miri, Ella Fudim, Orit Picard, et al.. (2023). Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?. Biomedicines. 11(6). 1553–1553. 4 indexed citations
3.
Yablecovitch, Doron, Hussein Mahajna, Nir Horesh, et al.. (2023). Serum matrix metalloproteinase-7: a potential biomarker in patients with Lynch Syndrome. Molecular Biology Reports. 50(9). 7471–7477. 1 indexed citations
4.
Ungar, Bella, Shani Ben‐Moshe, Keren Bahar Halpern, et al.. (2023). Distal Fecal Wash Host Transcriptomics Identifies Inflammation Throughout the Colon and Terminal Ileum. Cellular and Molecular Gastroenterology and Hepatology. 16(1). 1–15. 3 indexed citations
5.
Ungar, Bella, Miri Yavzori, Ella Fudim, et al.. (2022). Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD. Gut. 71(10). 1988–1997. 5 indexed citations
6.
Laish, Ido, Zohar Levi, Hussein Mahajna, et al.. (2022). Characterization of blood-derived exosomal hTERT mRNA as a biomarker for colon cancer and Lynch syndrome. Frontiers in Oncology. 12. 962473–962473. 4 indexed citations
7.
Ungar, Bella, Miri Yavzori, Orit Picard, et al.. (2020). Infliximab levels and antibodies in IBD-related peripheral arthralgia. International Journal of Colorectal Disease. 35(6). 1141–1148. 3 indexed citations
8.
Braun, Tzipi, Ayelet Di Segni, Sandra Neuman, et al.. (2019). Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease Flares. The American Journal of Gastroenterology. 114(7). 1142–1151. 53 indexed citations
9.
Vaisman‐Mentesh, Anna, Miri Yavzori, Yael Dror, et al.. (2019). Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists. Frontiers in Immunology. 10. 2921–2921. 44 indexed citations
10.
Lahat, Adi, Ariella Bar‐Gil Shitrit, Timna Naftali, et al.. (2017). Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 12(1). 120–123. 27 indexed citations
11.
Ungar, Bella, Uri Kopylov, Miri Yavzori, et al.. (2015). Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure. Medicine. 94(18). e673–e673. 16 indexed citations
12.
Ungar, Bella, Idan Levy, Yarden Yavne, et al.. (2015). Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology. 14(4). 550–557.e2. 276 indexed citations
13.
Katz, Lior H., Uri Kopylov, Ella Fudim, et al.. (2014). Expression of IL-2, IL-17 and TNF-alpha in patients with Crohn's disease treated with anti-TNF antibodies. Clinics and Research in Hepatology and Gastroenterology. 38(4). 491–498. 26 indexed citations
14.
Ben‐Horin, Shomron, Sylvie Polak‐Charcon, Iris Barshack, et al.. (2013). Celiac Disease Resolution After Allogeneic Bone Marrow Transplantation is Associated with Absence of Gliadin-Specific Memory Response by Donor-Derived Intestinal T-cells. Journal of Clinical Immunology. 33(8). 1395–1402. 7 indexed citations
15.
Kopylov, Uri, Yoav Mazor, Miri Yavzori, et al.. (2011). Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies. Inflammatory Bowel Diseases. 18(9). 1628–1633. 74 indexed citations
16.
Ben‐Horin, Shomron, Miri Yavzori, Lior H. Katz, et al.. (2010). The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful. Gut. 60(1). 41–48. 176 indexed citations
17.
Barshack, Iris, Mia Levite, Alon Lang, et al.. (2008). Functional Voltage-Gated Sodium Channels Are Expressed in Human Intestinal Epithelial Cells. Digestion. 77(2). 108–117. 21 indexed citations
18.
Ben‐Horin, Shomron, Itamar Goldstein, Ella Fudim, et al.. (2008). Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines. Gut. 58(3). 396–403. 45 indexed citations
19.
Fidder, Herma H., Sylviane Olschwang, Benjamin Avidan, et al.. (2003). Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients. American Journal of Medical Genetics Part A. 121A(3). 240–244. 24 indexed citations
20.
Meynard, J.‐L., Frédéric Barbut, Livia Blum, et al.. (1996). Risk Factors for Isolation of Streptococcus pneumoniae with Decreased Susceptibility to Penicillin G from Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 22(3). 437–440. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ella Fudim Breakdown of academic impact, for papers by Freddy Cornillie Breakdown of academic impact, for papers by Xavier Hébuterne Breakdown of academic impact, for papers by Francisco A. Bonilla Breakdown of academic impact, for papers by Marc Busson Breakdown of academic impact, for papers by Liesbet Henckaerts Breakdown of academic impact, for papers by Gilles Boschetti Breakdown of academic impact, for papers by Maya Ram Breakdown of academic impact, for papers by J Hors Breakdown of academic impact, for papers by David Hudesman
Rankless by CCL
2026